EP2523957A1 — Tricyclic heterocyclic compounds, compositions and methods of use thereof
Assigned to F Hoffmann La Roche AG · Expires 2012-11-21 · 13y expired
What this patent protects
The invention provides novel compounds of formula (I) having the general formula, wherein R 1 , R 2 , R 3 , X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyper…
USPTO Abstract
The invention provides novel compounds of formula (I) having the general formula, wherein R 1 , R 2 , R 3 , X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.